Latest News in the pharma Industry

Research & Development

BMS's Opdivo + Yervoy regimen receives expanded FDA approval

BMS's Opdivo + Yervoy regimen receives expanded FDA approval

24 Jan 2016

Opdivo + Yervoy Regimen now indicated for unresectable or metastatic melanoma patients, regardless of BRAF mutational status, based on accelerated approval.

Read more 
LDC enters new industry partnership for the discovery of novel medicines

LDC enters new industry partnership for the discovery of novel medicines

24 Jan 2016

LDC and Roche will jointly advance innovative drug discovery projects.

Read more 
Shire completes acquisition of Dyax

Shire completes acquisition of Dyax

23 Jan 2016

The addition of Kalbitor and DX-2930 to Shire's portfolio strengthens its leadership position in hereditary angioedema.

Read more 
Dynavax and AstraZeneca amend their agreement for asthma drug candidate

Dynavax and AstraZeneca amend their agreement for asthma drug candidate

20 Jan 2016

AstraZeneca to Conduct Phase IIa Clinical Study of AZD1419.

Read more 
Lilly and Incyte submit NDA to FDA for oral once-daily baricitinib

Lilly and Incyte submit NDA to FDA for oral once-daily baricitinib

20 Jan 2016

Baricitinib is for the treatment of moderate-to-severe rheumatoid arthritis.

Read more 
Sweeter treatment for breast and stomach cancers

Sweeter treatment for breast and stomach cancers

18 Jan 2016

Tweaking sugar molecules on anti-cancer antibodies improves cell-killing with fewer side effects.

Read more 
Centauri Therapeutics to develop novel anti-infective therapeutics

Centauri Therapeutics to develop novel anti-infective therapeutics

18 Jan 2016

Company has acquired Alphamer immuno-therapeutics platform technology.

Read more 
AbbVie announces positive top-line results from second Phase III study investigating Elagolix in patients with endometriosis

AbbVie announces positive top-line results from second Phase III study investigating Elagolix in patients with endometriosis

15 Feb 2016

Results show Elagolix reduces endometriosis-associated pain compared to placebo.

Read more 
Boehringer Ingelheim and Arena Pharmaceuticals collaborate to advance research in schizophrenia

Boehringer Ingelheim and Arena Pharmaceuticals collaborate to advance research in schizophrenia

14 Jan 2016

Collaboration partners to strengthen research in psychiatric diseases.

Read more 
Sanofi Pasteur provides key support to the Human Vaccines Project

Sanofi Pasteur provides key support to the Human Vaccines Project

14 Jan 2016

The research program is designed to accelerate the development of vaccines by decoding the human immune system.

Read more 
New NIH awards will support development of therapeutic alternatives to traditional antibiotics

New NIH awards will support development of therapeutic alternatives to traditional antibiotics

13 Jan 2016

NIAID awards approximately $5 million in funding for 24 research projects.

Read more 
FDA grants Priority Review for venetoclax NDA

FDA grants Priority Review for venetoclax NDA

12 Jan 2016

Venetoclax, an investigational medicine, is a potential new way of treating the most common adult leukemia.

Read more